Clinical Trial Update: Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing obeticholic acid versus placebo in combination with ursodeoxycholic acid for primary biliary cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Ocaliva (obeticholic acid)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: PBC | Phase 3 | Status: COMPLETED